World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
49
Citations
33542
World Ranking
4289
National Ranking
166

Taku Okazaki publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Taku Okazaki sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 85 publications — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Taku Okazaki D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Taku Okazaki sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 49 D-Index — 13th percentile

13% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Taku Okazaki is affiliated with the University of Tokushima in Japan and conducts research primarily within the fields of Medicine and Immunology and Microbiology. Their work encompasses multiple subfields including Oncology, Immunology, Neurology, Molecular Biology, and Biophysics. The main topics addressed in their research include:

  • Cancer Immunotherapy and Biomarkers
  • Immune Cell Function and Interaction
  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • T-cell and B-cell Immunology
  • Pancreatic and Hepatic Oncology Research
  • Neuroblastoma Research and Treatments

Among the notable recent papers associated with Taku Okazaki are:

  • "LAG-3: from molecular functions to clinical applications," 2020, Journal for ImmunoTherapy of Cancer
  • "Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunity," 2022, Immunity
  • "PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity," 2022, Nature Immunology
  • "PD-1 Imposes Qualitative Control of Cellular Transcriptomes in Response to T Cell Activation," 2020, Molecular Cell
  • "Robotic data acquisition with deep learning enables cell image-based prediction of transcriptomic phenotypes," 2022, Proceedings of the National Academy of Sciences

The frequent coauthors collaborating with Taku Okazaki include:

  • Il-mi Okazaki
  • Takumi Maruhashi
  • Daisuke Sugiura
  • Kenji Shimizu
  • Tatsuya Takemoto

Common publication venues for their work are:

  • Proceedings of the National Academy of Sciences
  • Biophysics and Physicobiology
  • Journal for ImmunoTherapy of Cancer
  • Immunity
  • Nature Immunology

Best Publications

  • Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.

    Gordon J. Freeman;Andrew J. Long;Yoshiko Iwai;Karen Bourque

  • Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

    Yoshiko Iwai;Masayoshi Ishida;Yoshimasa Tanaka;Taku Okazaki

  • PD-L2 is a second ligand for PD-1 and inhibits T cell activation

    Yvette Latchman;Clive R. Wood;Tatyana Chernova;Divya Chaudhary

  • Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice

    Hiroyuki Nishimura;Taku Okazaki;Yoshimasa Tanaka;Kazuki Nakatani

  • Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer.

    Junzo Hamanishi;Masaki Mandai;Masashi Iwasaki;Taku Okazaki

  • PD-1 and PD-1 ligands: from discovery to clinical application.

    Taku Okazaki;Tasuku Honjo

  • PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine

    Taku Okazaki;Akito Maeda;Hiroyuki Nishimura;Tomohiro Kurosaki

  • A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application.

    Taku Okazaki;Shunsuke Chikuma;Yoshiko Iwai;Sidonia Fagarasan

  • The PD-1–PD-L pathway in immunological tolerance

    Taku Okazaki;Tasuku Honjo

  • Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma†

    Ryosuke Hino;Kenji Kabashima;Kenji Kabashima;Yu Kato;Hiroaki Yagi

  • Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice

    Taku Okazaki;Yoshimasa Tanaka;Yoshimasa Tanaka;Ryosuke Nishio;Tamotsu Mitsuiye

  • Human Obese Gene Expression: Adipocyte-Specific Expression and Regional Differences in the Adipose Tissue

    Hiroaki Masuzaki;Yoshihiro Ogawa;Naohi Isse;Noriko Satoh

  • Resting dendritic cells induce peripheral CD8 + T cell tolerance through PD-1 and CTLA-4

    Hans Christian Probst;Kathy McCoy;Taku Okazaki;Tasuku Honjo

  • The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors.

    David Yin-wei Lin;Yoshimasa Tanaka;Masashi Iwasaki;Apostolos G. Gittis

  • Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes

    Jian Wang;Taku Yoshida;Fumio Nakaki;Hiroshi Hiai

  • PD-1 Inhibits Antiviral Immunity at the Effector Phase in the Liver

    Yoshiko Iwai;Seigo Terawaki;Masaya Ikegawa;Taku Okazaki

  • LAG-3: from molecular functions to clinical applications

    Takumi Maruhashi;Daisuke Sugiura;Il Mi Okazaki;Taku Okazaki

  • IFN-α Directly Promotes Programmed Cell Death-1 Transcription and Limits the Duration of T Cell-Mediated Immunity

    Seigo Terawaki;Shunsuke Chikuma;Shiro Shibayama;Tamon Hayashi

  • Structural organization and chromosomal assignment of the human obese gene.

    Naohi Isse;Yoshihiro Ogawa;Naohisa Tamura;Hiroaki Masuzaki

  • Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues.

    Masayoshi Ishida;Yoshiko Iwai;Yoshimasa Tanaka;Taku Okazaki

  • Role of PD-1 in regulating T-cell immunity.

    Hyun-Tak Jin;Rafi Ahmed;Taku Okazaki

  • PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice

    Taku Okazaki;Il-mi Okazaki;Jian Wang;Daisuke Sugiura

  • Adipocyte-Specific Expression and Regional Differences in the Adipose Tissue

    Hiroaki Masuzaki;Yoshihiro Ogawa;Naohi Isse;Noriko Satoh

Frequent Co-Authors

Tasuku Honjo
Tasuku Honjo Kyoto University
Yoshimasa Tanaka
Yoshimasa Tanaka Nagasaki University
Nagahiro Minato
Nagahiro Minato Kyoto University
Yoshihiro Ogawa
Yoshihiro Ogawa Kyushu University
Hiroshi Hiai
Hiroshi Hiai Kyoto University
Kazuwa Nakao
Kazuwa Nakao Kyoto University
Kiyoshi Mori
Kiyoshi Mori University of Shizuoka
Tsutomu Chiba
Tsutomu Chiba Kyoto University
Kiminori Hosoda
Kiminori Hosoda Kyoto University
Hiroaki Masuzaki
Hiroaki Masuzaki University of the Ryukyus

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, expanding into related healthcare fields can offer diverse career opportunities. Many professionals pursue advanced nursing roles that integrate immunological knowledge, such as Psychiatric-Mental Health Nurse Practitioners (PMHNPs). Top programs in this area highlight the importance of clinical experience, and you can explore options through top pmhnp programs.

Cost is also a key factor for many online learners. Identifying affordable pathways is crucial for long-term success, especially for specializations closely tied to immunology like psychiatric nursing. Students aiming to balance quality and expense may consider the cheapest psychiatric nurse practitioner programs available.

Salary expectations vary by state and specialization, which can influence career decisions after completing a degree in immunology or related fields. For example, those holding a Doctor of Nursing Practice (DNP) degree should review data on earnings to plan accordingly. Detailed information can be found in resources about the dnp salary.

For practicing nurses considering specialization, transition programs offer tailored pathways to acute care roles, often complementing an immunology background. Professionals can enhance their scope of practice through programs like the fnp to acute care np bridge program, which bridges family nurse practitioner (FNP) skills to acute care expertise.

Best Scientists Citing Taku Okazaki

Trending Scientists

Recently Published Articles